Nephro Care India SME IPO Details, Financials, Valuation & Peers
Get everything you need to know about the Nephro Care India IPO. Explore Nephro Care India IPO details, including IPO dates, financial statements, valuation, peer comparison, and more.
Overview
Nephro Care India Limited, founded in 2014 by Dr. Pratim Sengupta in Kolkata, is dedicated to providing comprehensive medical services for renal patients. The term renal refers to anything related to the kidneys. The company has grown from its initial offerings of dialysis and renal OPD services in third-party facilities to operating its own daycare units and dialysis centers. Nephro Care's holistic treatment framework covers the entire range of lifestyle, physiological, and spiritual aspects of wellness, supported by a team of expert doctors, well-trained paramedical professionals, and skilled management.
Key Points:
- Expansion and Infrastructure Development:
- Daycare Unit: In December 2021, Nephro Care established its own daycare unit at JC-18, Salt Lake, Kolkata, expanding its range of services.
- HB 113 Facility: The company entered into an agreement with e-Age Healthcare to take over a dialysis unit at HB 113, Salt Lake City, Kolkata. This facility, operational since July 2023, includes 11 dialysis machines and operates under Nephro Care’s management.
- Healthcare Services and Facilities: Nephro Care offers a comprehensive range of services to cater to various healthcare needs:
- Inhouse Dialysis Unit: Equipped with advanced technology for efficient dialysis treatment.
- Outpatient Services: Covering nephrology, diabetology, cardiology, ophthalmology, and neurology.
- NABL Accredited Pathology: Ensures high-quality diagnostic services.
- Inhouse Pharmacy: Provides convenient access to necessary medications.
- Advanced Diagnostic Facilities: Includes a wide spectrum of diagnostic tools to support accurate medical evaluations.
- Renal Nutrition Department: Offers specialized dietary guidance for renal patients.
- Home Care Services: Extends healthcare services to patients' homes for added convenience.
- Mukti (Lifestyle Support Program): Integrates lifestyle and wellness support with medical care.
- Home Dialysis: Facilitates dialysis treatment in the comfort of patients' homes.
- Vision and Mission: Nephro Care aims to leverage a holistic approach, combining modern medical practices with time-tested yogic wisdom to improve the lives of kidney disease patients. The company envisions reaching out to one million kidney disease patients across India through a hub-and-spoke model, providing accessible and high-quality renal care.
- Patient and Staff Base:
- Patient Reach: Currently serves around 900 Chronic Kidney Disease (CKD) patients monthly.
- Medical Team: Comprises over 5 permanent doctors, 10 visiting consultants, and 70 experienced paramedical professionals.
- Clinic Locations: Operates a flagship clinic in Salt Lake and three satellite clinics, with plans for further expansion.
- New Clinics: Agreements have been executed for new clinics in Alipurduar (West Bengal), Shyambazar (Kolkata, West Bengal), and Balasore (Odisha).
- Madhyamgram Hospital: Plans to convert a 60-bed hospital in Madhyamgram, Kolkata into a 100-bed multi-speciality hospital. Part of the IPO proceeds is intended for this project.
Objects of the Issue
- Setting up of Multi Speciality Hospital in the name of “Vivacity Multi Specialty Hospital” (unit of Nephro Care) at Kolkata (Madhyamgaram), West Bengal
- General Corporate Expenses
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 28 Jun - 02 Jul 2024 |
| IPO Price Band | ₹ 85 - 90 per share |
| Fresh Issue | 45,84,000 shares |
| Offer For Sale | NIL |
| Total IPO Size | Approx ₹ 41.26 crore |
| Face Value | ₹ 10 |
| Listing On | NSE |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 28 Jun 2024 |
| IPO Closing Date | 02 Jul 2024 |
| Basis Of Allotment | 03 Jul 2024 |
| Refunds | 04 Jul 2024 |
| Demat Transfer | 04 Jul 2024 |
| IPO Listing Date | 05 Jul 2024 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | Dec 2023 |
|---|---|---|---|---|
| Total Income | 1.83 | 3.43 | 17.10 | 19.90 |
| Total Expenses | 1.71 | 3.43 | 14.38 | 15.30 |
| Net Profit/Loss | 0.09 | -0.01 | 1.94 | 3.40 |
| NPM (*) | 4.86 | -0.29 | 11.36 | 17.22 |
| Total Assets | 1.13 | 4.63 | 8.31 | 20.30 |
| Total Liabilities | 1.11 | 4.13 | 5.87 | 6.38 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Valuation
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
| Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | Dec 2023 |
|---|---|---|---|---|
| EPS | 4.44 | -0.03 | 1.94 | 3.36 |
| ROE (%) | 182.89 | -3.84 | 132.46 | 41.57 |
| ROCE (%) | 21.42 | 4.13 | 71.09 | 36.56 |
| RoNW (%) | 591.33 | -1.98 | 79.68 | 24.42 |
| D/E Ratio | 14.28 | 9.95 | 1.68 | NA |
| Current Ratio | 1.08 | 0.66 | 0.86 | 0.87 |
| EBITDA MARGIN (%) | 8.47 | 3.67 | 21.33 | 25.55 |
* Compiled from DRHP/RHP for valuation purposes.
Peer Comparison
No listed peers available for comparison.
Subscription Data from NSE and BSE
| Investor Type | Subscribed |
|---|---|
| Qualified Institutional Buyer (QIB) | 245.14 |
| Non-Institutional Investor (NII/HNI) | 1787.19 |
| Retail Individual Investor (RII) | 634.12 |
| Total | 715.78 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
IPO Registrar
Bigshare Services Private Limited
Phone: +91 22-62638200
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com
Company Promoters
- DR. PRATIM SENGUPTA
- DR. PRITAM SENGUPTA
- DR. SUTAPA SEN
Lead Managers
- CORPORATE CAPITAL VENTURES PRIVATE LIMITED
Company Address
Nephro Care India Limited
Flat No-1JC-18, 5th Floor Sec-III, Salt lake Kolkata, Bidhan Nagar Sai Complex, North 24 Parganas -700098 West Bengal, India
Phone: +91 8017010197
Email: cs@nephrocareindia.com
Website: www.nephrocareindia.com
FAQs
- What is the issue size of the Nephro Care India SME IPO?The Nephro Care India SME IPO has an issue size of Approx ₹ 41.26 crore. This includes a fresh issue of 45,84,000 shares and an offer for sale (OFS) of NIL.
- What is the price band of the Nephro Care India IPO?The price band for the Nephro Care India IPO is ₹ 85 - 90 per share.
- What are the bidding dates for the Nephro Care India IPO?The Nephro Care India IPO will open for bidding on 28 Jun 2024 and close on 02 Jul 2024.
- What is the allotment date for the Nephro Care India IPO?The allotment date for the Nephro Care India IPO is 03 Jul 2024.
- What is the listing date for the Nephro Care India IPO?The listing date for the Nephro Care India IPO is 05 Jul 2024.
- What is the Nephro Care India IPO grey market premium?The grey market premium (GMP) for the Nephro Care India IPO is currently at ₹175, with an expected listing gain of approximately 194.44%. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.